# Shoulder Innovations, Inc.: filings

SI · NYSE · CIK 1699350 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/si.md) · [Financials](/companies/si/financials.md) · [Filings](/companies/si/filings.md) · [Insiders](/companies/si/insiders.md)

## Reports and events: 26 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 50, 3 14, 8-K 14, D 6, CORRESP 5, SCHEDULE 13G 5, 10-Q 4, 144 4, UPLOAD 4, S-1/A 3, DRS/A 2, DRSLTR 2, EFFECT 2, S-8 2, SCHEDULE 13G/A 2, 10-K 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, D/A 1, DEF 14A 1, DEFA14A 1, DRS 1, FWP 1, S-1 1, S-3 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 11:05 ET | [8-K](/filings/0001699350-26-000058.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000058 |
| 2026-08-10 | 11:09 ET | [8-K](/filings/0001699350-26-000054.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000054 |
| 2026-08-07 | 21:08 ET | [SCHEDULE 13D/A](/filings/0001193125-26-340485.md) | Ownership report, active investor, amended | 0001193125-26-340485 |
| 2026-08-06 | 21:14 ET | [10-Q](/filings/0001699350-26-000052.md) | Quarterly report, period 2026-06-30 | 0001699350-26-000052 |
| 2026-08-06 | 20:12 ET | [8-K](/filings/0001699350-26-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699350-26-000050 |
| 2026-06-29 | 11:07 ET | [8-K](/filings/0001699350-26-000044.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000044 |
| 2026-06-26 | 20:09 ET | [8-K](/filings/0001699350-26-000042.md) | 5.07 Shareholder vote results | 0001699350-26-000042 |
| 2026-05-13 | 20:26 ET | [10-Q](/filings/0001699350-26-000035.md) | Quarterly report, period 2026-03-31 | 0001699350-26-000035 |
| 2026-05-13 | 20:08 ET | [8-K](/filings/0001699350-26-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699350-26-000033 |
| 2026-04-29 | 12:38 ET | [DEF 14A](/filings/0001699350-26-000026.md) | Proxy statement, period 2026-06-26 | 0001699350-26-000026 |
| 2026-04-27 | 11:05 ET | [8-K](/filings/0001699350-26-000021.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000021 |
| 2026-04-14 | 20:31 ET | [8-K](/filings/0001699350-26-000016.md) | 1.01 Entry into a material agreement | 0001699350-26-000016 |
| 2026-03-10 | 20:20 ET | [10-K](/filings/0001699350-26-000011.md) | Annual report, period 2025-12-31 | 0001699350-26-000011 |
| 2026-03-10 | 20:09 ET | [8-K](/filings/0001699350-26-000010.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001699350-26-000010 |
| 2026-03-02 | 12:07 ET | [8-K](/filings/0001699350-26-000003.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000003 |
| 2025-12-03 | 12:10 ET | [8-K](/filings/0001699350-25-000020.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-25-000020 |
| 2025-11-12 | 21:10 ET | [10-Q](/filings/0001699350-25-000017.md) | Quarterly report, period 2025-09-30 | 0001699350-25-000017 |
| 2025-11-12 | 14:13 ET | [8-K](/filings/0001699350-25-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699350-25-000015 |
| 2025-09-09 | 20:12 ET | [10-Q](/filings/0001699350-25-000011.md) | Quarterly report, period 2025-06-30 | 0001699350-25-000011 |
| 2025-09-09 | 11:10 ET | [8-K](/filings/0001699350-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699350-25-000008 |
| 2025-08-05 | 22:49 ET | [SCHEDULE 13D](/filings/0000950170-25-103320.md) | Ownership report, active investor | 0000950170-25-103320 |
| 2025-08-04 | 20:09 ET | [8-K](/filings/0001628280-25-037418.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-25-037418 |
| 2025-07-25 | 16:29 ET | [S-1/A](/filings/0001628280-25-036019.md) | Registration statement, amended | 0001628280-25-036019 |
| 2025-07-24 | 11:00 ET | [S-1/A](/filings/0001628280-25-035833.md) | Registration statement, amended | 0001628280-25-035833 |
| 2025-07-09 | 21:17 ET | [S-1/A](/filings/0001628280-25-034668.md) | Registration statement, amended | 0001628280-25-034668 |
| 2025-07-07 | 21:22 ET | [S-1](/filings/0001628280-25-034437.md) | Registration statement | 0001628280-25-034437 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.